Suppr超能文献

超越疼痛缓解:大麻二酚在医学治疗中的潜力综述

Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies.

作者信息

Luz-Veiga Mariana, Azevedo-Silva João, Fernandes João C

机构信息

CBQF-Centro de Biotecnologia e Química Fina-Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, 4169-005 Porto, Portugal.

Amyris Bio Products Portugal, Unipessoal Lda, 4169-005 Porto, Portugal.

出版信息

Pharmaceuticals (Basel). 2023 Jan 20;16(2):155. doi: 10.3390/ph16020155.

Abstract

The phytocannabinoid cannabidiol (CBD) is receiving increasing attention due to its pharmacological properties. Although CBD is extracted from , it lacks the psychoactive effects of Δ9-tetrahydrocannabinol (THC) and has become an attractive compound for pharmacological uses due to its anti-inflammatory, antioxidant, anticonvulsant, and anxiolytic potential. The molecular mechanisms involved in CBD's biological effects are not limited to its interaction with classical cannabinoid receptors, exerting anti-inflammatory or pain-relief effects. Several pieces of evidence demonstrate that CBD interacts with other receptors and cellular signaling cascades, which further support CBD's therapeutic potential beyond pain management. In this review, we take a closer look at the molecular mechanisms of CBD and its potential therapeutic application in the context of cancer, neurodegeneration, and autoimmune diseases.

摘要

植物大麻素大麻二酚(CBD)因其药理特性而受到越来越多的关注。尽管CBD是从[具体来源未提及]中提取的,但它缺乏Δ9-四氢大麻酚(THC)的精神活性作用,并且由于其抗炎、抗氧化、抗惊厥和抗焦虑潜力,已成为一种有吸引力的药用化合物。参与CBD生物学效应的分子机制不仅限于其与经典大麻素受体的相互作用,从而发挥抗炎或止痛作用。多项证据表明,CBD与其他受体和细胞信号级联相互作用,这进一步支持了CBD在疼痛管理之外的治疗潜力。在这篇综述中,我们更深入地探讨了CBD的分子机制及其在癌症、神经退行性疾病和自身免疫性疾病背景下的潜在治疗应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a429/9958812/458cf1cf7d3e/pharmaceuticals-16-00155-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验